Towards selective pharmacological modulation of protein kinase C – opportunities for the development of novel antineoplastic agents
- 1 July 1992
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 66 (1) , 10-19
- https://doi.org/10.1038/bjc.1992.209
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Chelerythrine is a potent and specific inhibitor of protein kinase CPublished by Elsevier ,2004
- The modulation of growth by HMBA in PKC overproducing HT29 colon cancer cellsBiochemical and Biophysical Research Communications, 1991
- RO 31-8220 and RO 31-7549 show improved selectivity for protein kinase C over staurosporine in macrophagesBiochemical and Biophysical Research Communications, 1991
- Differential recovery of protein kinase C-α and -ɛ isozymes after long-term phorbol ester treatment in rat renal mesangial cellsBiochemical and Biophysical Research Communications, 1991
- Down-regulation of protein kinase C in Swiss 3T3 fibroblasts is independent of its phosphorylating activityBiochemical and Biophysical Research Communications, 1991
- Proteolytic activation of protein kinase C‐ɛEuropean Journal of Biochemistry, 1990
- Protein kinase C-γ is present in adriamycin resistant HL-60 leukemia cellsBiochemical and Biophysical Research Communications, 1990
- Differentiative action of K252a on protein kinase C and A calcium-unresponsive, phorbol ester/phospholipid-activated protein kinaseBiochemical and Biophysical Research Communications, 1989
- Inhibition of protein kinase C by sphingosine correlates with the presence of positive chargeBiochemical and Biophysical Research Communications, 1989
- Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase CBiochemical and Biophysical Research Communications, 1989